Intended Use: Qualitative detection of fetal fibronectin in cervicovaginal secretions. The presence of fetal fibronectin in cervicovaginal secretions between 22 weeks, 0 days and 34 weeks, 6 days of gestation is associated with elevated risk of preterm delivery.
Century Emperor North Tower, Jiangbei District, Chongqing,China
About Dezhixing
We are committed to providing comprehensive and high-quality medical consumables products and services for patients, hospitals, medical institution partners, and more.
China Sichuan Dezhixing Medical Equipment Co., Ltd.